William D Cress
Has grant
Senior Member
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Recent Grants
Grant: Open
Targeting centrosome‐mitotic kinases as a novel therapeutic approach against breast cancers in Hispanic/Latinas.
Open Date: 2022-09-15
Close Date: 2027-08-31
Grant: Close
Molecular Drivers of Lung Cancer in Hispanics
Open Date: 2022-01-01
Close Date: 2024-12-31
Grant: Close
Identifying Metabolic Vulnerabilities in Lung Cancer
Open Date: 2021-06-25
Close Date: 2026-05-31
Grant: Close
Integrated Program in Cancer and Data Science
Open Date: 2019-09-16
Close Date: 2025-08-31
Grant: Close
1/2 Southeast Partnership for Improving Research & Training in Cancer Health Disparities
Open Date: 2017-09-21
Close Date: 2022-08-31
Articles (19)
Admixed populations, including the Hispanic/Latino/a community, are underrepresented in cancer genetic/genomic studies. Leveraging the Latino Colorectal Cancer Consortium (LC3) and other existing datasets, we analyzed whole-exome sequencing data on tumor/normal pairs from 718 individuals with colorectal cancer to map somatic mutational features by ethnicity and genetic similarity. Global proportions of African, Asian, European, and Native American genetic ancestries were estimated using ADMIXTURE. Associations between these proportions and somatic mutational features were examined using logistic regression. APC, TP53, and KRAS were the top three mutated genes across all participants and in the subset of Latino individuals in LC3. In analyses examining recurrently mutated genes, tumors from patients of Latino ethnicity had fewer KRAS and PIK3CA mutations compared with tumors from non-Latino patients. Genetic ancestry overall was associated with CDC27 mutation status, and African genetic ancestry was associated with SMAD2 mutation status. In exome-wide analyses, African genetic ancestry was significantly associated with higher odds of mutation in KNCN and TMEM184B. Native American genetic ancestry was associated with a lower frequency of microsatellite instability–high tumors. The SBS11 mutational signature was associated with Native American genetic ancestry as well as Latino ethnicity. In an independent replication dataset, MSK-IMPACT, estimates of association were largely consistent in direction but nonsignificant. A meta-analysis of LC3 and MSK-IMPACT showed that African genetic ancestry was significantly associated with KRAS mutation status and MSI status. This work facilitates precision medicine initiatives by providing insights into the contribution of genetic ancestry to molecular features of colorectal tumors. Significance: Analysis of tumors from various populations can broadly characterize genomic landscapes and enhance precision medicine strategies.
Year:
2025
Breast cancer is a leading cause of cancer-related mortality among women worldwide and is known to have higher mortality among women with African ancestry. Herein, we describe the creation and characterization of a multiethnic breast cancer tissue microarray (ME-BrTMA) representing tumors from non-Hispanic White (n = 41), non-Hispanic Black (NHB; n = 45), and Hispanic patients from Puerto Rico (n = 36) and Florida (n = 52). This ME-BrTMA comprises five blocks with a total of 610 cores: 371 breast cancer tumor cores, 93 breast stromal cores, 96 normal breast tissue cores, 30 non–breast cancer tumor cores, and 20 cores representing normal tissues. Initial characterization of the ME-BrTMA includes standard IHC staining of well-characterized clinical biomarkers, including the estrogen hormone receptors and progesterone hormone receptors, HER2, and Ki-67, interpreted by the coauthoring pathologist (Marilin Rosa). The IHC results indicated good but imperfect alignment with clinical diagnoses. Cores from breast cancer tumors from the NHB cohort most frequently scored negative for estrogen receptor (63%, P < 0.005) and progesterone receptor (80%, P < 0.005) and most frequently have high expression of the Ki-67 proliferation marker (38%, P < 0.05). Prediction Analysis of Microarray 50 (PAM50) analysis using RNA from secondary patient blocks showed that the NHB group also most frequently scored in the basal-like category (61%, P < 0.05). Taken together, the initial characterization of the ME-BrTMA suggests that it may serve as a representative resource to understand the underlying biology of breast cancer and its relationship to patient outcomes. Significance: The ME-BrTMA described herein provides a resource that may serve as a tool to understand the underlying biology of breast cancer.
Year:
2025
Introduction Incidence of endometrial cancer (EC) in Hispanic/Latina (H/L) women are higher compared to other race/ethnicities in the United States. EC is the third most common cancer and the fourth cause of cancer-related deaths in Puerto Rican women, yet demographic and clinical information is limited. High rates of EC risk factors such as obesity, diabetes mellitus type 2 (DM2) and hypertension (HTN) have been documented in the Puerto Rican population. Objective To describe the demographic, clinical history, lifestyle, obstetrical-gynecological, pathologic, and molecular profiles of women with EC predominantly from Southern/Central Puerto Rico. Methods We conducted a retrospective secondary analysis of data abstracted from the Puerto Rico Central Cancer Registry (PRCCR), self-administered questionnaires and medical records of EC cases. Descriptive statistics were conducted using SPSS V28 and RStudio. Results We identified 105 EC cases aged 28–82. The major risk factors were BMI ≥ 30 (72%), HTN (33%), and DM2 (20%). Endometrioid adenocarcinoma was the main histological tumor type (80%), of which 74% were Type I. Obesity and nulliparity were associated with younger age at diagnosis. Older age at diagnosis (> 65 y/o) was associated with more advanced disease. Conclusions This study defined the clinical-demographic profile of women with EC from Puerto Rico and identified risks factors that are associated with younger or older age at diagnosis. Impact Profiling the risk factors for EC may help improve diagnostic accuracy and clinical management and result in better outcomes for this under-served, under-researched cancer patient population.
Year:
2025
TNBC is most common in the NHB cohort. A, Stacked bar chart showing the fraction of patients with each level of HER2 expression among the four cohorts ( P = 0.387, χ 2 test). B, Stacked bar chart showing that the HR−/HER2− (triple-negative) phenotype is more frequent in the cores from the NHB patients ( P = 0.004, Fisher exact test). HR, hormone receptor (ER and PR); PPN, percent positive nuclei.
Year:
2025
High expression of the proliferative marker Ki-67 is more frequent among cores from the NHB cohort. A, Boxplots comparing Ki-67% positivity as a function of the cohort. B, Risk categories for Ki-67 (low risk, 14 PPN) are shown as stacked bar charts. Supplementary Table S13 tabulates these data (see rows Ki-67 PPN and Ki-67 risk category). PPN, percent positive nuclei.
Year:
2025
Breast cancer is a leading cause of cancer-related mortality among women worldwide and is known to have higher mortality among women with African ancestry. Herein, we describe the creation and characterization of a multiethnic breast cancer tissue microarray (ME-BrTMA) representing tumors from non-Hispanic White ( n = 41), non-Hispanic Black (NHB; n = 45), and Hispanic patients from Puerto Rico ( n = 36) and Florida ( n = 52). This ME-BrTMA comprises five blocks with a total of 610 cores: 371 breast cancer tumor cores, 93 breast stromal cores, 96 normal breast tissue cores, 30 non–breast cancer tumor cores, and 20 cores representing normal tissues. Initial characterization of the ME-BrTMA includes standard IHC staining of well-characterized clinical biomarkers, including the estrogen hormone receptors and progesterone hormone receptors, HER2, and Ki-67, interpreted by the coauthoring pathologist (Marilin Rosa). The IHC results indicated good but imperfect alignment with clinical diagnoses. Cores from breast cancer tumors from the NHB cohort most frequently scored negative for estrogen receptor (63%, P P P P Significance: The ME-BrTMA described herein provides a resource that may serve as a tool to understand the underlying biology of breast cancer.
Year:
2025
PAM50 analysis shows that basal-like subtype is most frequent among NHBs. Stacked bar chart shows the results of PAM50 gene expression analysis on patients represented on the ME-BrTMA with available RNA sequencing data. The data show that the basal-like subtype is most frequent among NHBs represented on the TMA ( P = 0.031). Supplementary Table S15 tabulates the PAM50 subgroup breakdown by cohort. Note that RNA sequencing data for the NHW patients in cohort 1 are not included because they are not available.
Year:
2025
The frequency of ER-negative and PR-negative expression is highest in tumor cores from patients in the NHB cohort. A, Stacked bar chart showing that the frequency of negative ER expression is highest in cores from the NHB cohort (Fisher exact test, P = 0.001). B, Stacked bar chart showing that the frequency of PR-negative expression is highest in cores from the NHB cohort (χ 2 test, P = 0.003). C, Stacked bar chart showing that the frequency of HR-negative expression is highest in cores from the NHB cohort (χ 2 test, P = 0.006, χ 2 test). PPN, percent positive nuclei.
Year:
2025
Supplementary Materials includes participants and biospecimens, sample selection, sequence trimming, sequence alignment, alignment refinement, germline variant calling, somatic mutation detection, population-level somatic mutation allele frequency filter, sample processing for genetic ancestry modeling, and population structure estimation.
Year:
2025
Admixed populations, including the Hispanic/Latino/a community, are underrepresented in cancer genetic/genomic studies. Leveraging the Latino Colorectal Cancer Consortium (LC3) and other existing datasets, we analyzed whole-exome sequencing data on tumor/normal pairs from 718 individuals with colorectal cancer to map somatic mutational features by ethnicity and genetic similarity. Global proportions of African, Asian, European, and Native American genetic ancestries were estimated using ADMIXTURE. Associations between these proportions and somatic mutational features were examined using logistic regression. APC , TP53 , and KRAS were the top three mutated genes across all participants and in the subset of Latino individuals in LC3. In analyses examining recurrently mutated genes, tumors from patients of Latino ethnicity had fewer KRAS and PIK3CA mutations compared with tumors from non-Latino patients. Genetic ancestry overall was associated with CDC27 mutation status, and African genetic ancestry was associated with SMAD2 mutation status. In exome-wide analyses, African genetic ancestry was significantly associated with higher odds of mutation in KNCN and TMEM184B . Native American genetic ancestry was associated with a lower frequency of microsatellite instability–high tumors. The SBS11 mutational signature was associated with Native American genetic ancestry as well as Latino ethnicity. In an independent replication dataset, MSK-IMPACT, estimates of association were largely consistent in direction but nonsignificant. A meta-analysis of LC3 and MSK-IMPACT showed that African genetic ancestry was significantly associated with KRAS mutation status and MSI status. This work facilitates precision medicine initiatives by providing insights into the contribution of genetic ancestry to molecular features of colorectal tumors. Significance: Analysis of tumors from various populations can broadly characterize genomic landscapes and enhance precision medicine strategies.
Year:
2025
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Collaborators (9)
Idhaliz Flores
Professor
Ponce Health Sciences University
Mariana C. Stern
Professor
University of Southern California
José Antonio Oliveras Torres
Assistant Professor / Puerto Rico BioBank Co-leader
Ponce Health Sciences University
Harold I Saavedra
Professor
Ponce Health Sciences University
Steven Eschrich
Professor
H Lee Moffitt Cancer Center and Research Institute
Brooke Fridley
Director
Children's Mercy Hospital
Kun Jiang
-
Kritika Shankar
University of Connecticut
Dung-Tsa Chen
H Lee Moffitt Cancer Center and Research Institute
Make your next move.
Prepare your application
Review drafts before you send them.